Regulation & law · 22/10/2002Updated: 10/17/2026 · 1 min read
Hemagen Diagnostics, Inc. Seeks to Withdraw Common Stock from Boston Stock Exchange Listing
Summary
Hemagen Diagnostics, Inc. has submitted a notice to withdraw its common stock from listing and registration on the Boston Stock Exchange, effective File No. 1-11700.
Original source language: Federal Register — All DocumentsOpen original release →